戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ed by SCLC, but over 70% of SCLC contain the c-Kit receptor.
2 es alpha6-integrin, alphav-integrin, and the c-kit receptor.
3 by FRET, and tyrosine phosphorylation of the c-kit receptor.
4 report, a similar approach is applied to the c-kit receptor.
5 tor of Ras, via wild-type and mutant (W(41)) c-kit receptors.
6 ine, CTS, which expresses both the CXCR4 and c-kit receptors.
7 y and immunoreactivity to antibodies against c-Kit receptors.
8 ent with the expression of a single class of c-kit receptors.
9 in c-kit or stem cell factor, the ligand for c-Kit receptors.
10       We used an antibody against the murine c-Kit receptor (ACK2) to deplete fetal host hematopoieti
11 hanistically, these effects were mediated by c-Kit receptor activation, STAT5 phosphorylation, and re
12 ata suggest that interaction of SCF with the c-kit receptor affects the homing behavior of hematopoie
13 disruption leads to a destabilization of the c-Kit receptor and decreased survival of cells.
14                   By targeting the mast cell c-Kit receptor and inhibiting mast cell activation and d
15                                          The c-kit receptor and its ligand, steel factor (SLF), are c
16 known about the biological properties of the c-kit receptor and its ligand, stem cell factor (SCF), l
17 uggest that exposure to Epo can activate the c-kit receptor and provide further evidence for cross-ta
18 ontrast to other tumor cells, CSCs expressed c-kit receptors and produced SCF.
19 and NCI-H249) SCLC cell lines had detectable c-Kit receptors and were inhibited in growth and viabili
20 involved in LC development, including GATA4, c-kit receptor, and leukemia inhibitory factor receptor.
21 ral tyrosine kinases, including BCR-ABL, the C-KIT receptor, and the platelet-derived growth factor r
22                                              c-Kit receptors are expressed in proliferating adult CE
23 ells with further recruitment of JAK2 to the c-kit receptor complex after SCF stimulation.
24                                   The mutant c-Kit receptor confers cytokine independence and induces
25                                   The mutant c-Kit receptor confers cytokine-independent survival of
26 e as they home and engraft in irradiated and c-Kit-receptor-deficient recipient mice.
27 ed cytokine thrombopoietin (Tpo), stimulated c-kit receptor dimerization detectable by FRET, and tyro
28                 Prior biochemical studies of c-kit receptor dimerization have mainly used affinity cr
29 echnique is sufficiently sensitive to detect c-kit receptor dimerization on normal human hematopoieti
30     SCF induced a dose-dependent increase in c-kit receptor dimerization that correlated well with th
31                 The ability of SCF to induce c-kit receptor dimerization was assessed by flow cytomet
32  of SCF and other hematopoietic cytokines on c-kit receptor dimerization.
33 the white spotting locus that causes reduced c-Kit receptor expression and an inability of mast cells
34                         The up-regulation of c-kit receptor expression in diseased livers suggests an
35 skin, these results suggest that the loss of c-KIT receptor expression may allow malignant melanoma c
36 xtent of mediator release induced by SCF and c-kit receptor expression.
37 ocal microscopy showed redistribution of the c-kit receptor (from a diffuse distribution on the cell
38                   These results suggest that c-kit receptor function may be required for optimal resp
39 poietic cells to the spleen was dependent on c-kit receptor function.
40 he platelet-derived growth factor (PDGF) and c-kit receptors has been proposed as important in mediat
41 rosine-phosphorylated upon activation of the c-Kit receptor, implicating it as a component of a signa
42 b is strictly required for expression of the c-Kit receptor in erythroid cells.
43 ular conjugate adenovirus vector through the c-kit receptor in hematopoietic progenitor cell lines.
44   PTP-RO was found to be associated with the c-Kit receptor in these transfected cells and the SCF/Ki
45      The extensive expression of the Erb and c-kit receptors in adult taste buds and in and around de
46  evidence for cross-talk between the Epo and c-kit receptors in human hematopoietic cell lines.
47 ptor shares several characteristics with the c-kit receptor including dimerization and rapid internal
48 ic microenvironment is more dependent on SCF/c-kit receptor interaction than is erythropoiesis in the
49 trong evidence that, during development, the c-kit receptor is expressed in different pools of cardia
50 d new protein synthesis, suggesting that the c-kit receptor is not recycled to the cell surface after
51                                          The c-Kit receptor is regarded as one of the CSC markers in
52      Stem cell factor (SCF), a ligand of the c-kit receptor, is a critical cytokine, which contribute
53 with PKC412 (an inhibitor of PDGF, VEGF, and c-kit receptor kinases and several isoforms of PKC), PTK
54 KC), PTK787 (an inhibitor of PDGF, VEGF, and c-kit receptor kinases), SU1498 (an inhibitor of VEGF re
55 n contrast to the pleiotropic effects of the c-kit receptor ligand, stem cell factor.
56 brane targeted fusion protein containing the c-kit receptor linked to one or more copies of FKBP12 al
57                     The nonneutralizing anti-c-kit receptor monoclonal antibody 104D2 was directly co
58                             Mutations in the c-KIT receptor occur somatically in many sporadic Gastro
59                          Reappearance of the c-kit receptor on the cell surface required new protein
60 topoietic cells that universally express the c-Kit receptor on their cell surface.
61 al involvement in the stem cell factor (SCF)/c-Kit receptor pathway, COS-7 and 293 cells were cotrans
62 75 (CT53518), inhibits Flt-3, betaPDGFR, and c-Kit receptor phosphorylation with IC(50) values of 50-
63 5 d, surviving hair bulb melanocytes express c-kit receptor, proliferate, and appear to migrate up th
64 ity of only two of these genes is known: the c-kit receptor protein tyrosine kinase and the c-kit lig
65                          The activity of the c-Kit receptor protein-tyrosine kinase is tightly regula
66 ly kinase (SFK) binding sites in the mutated c-Kit receptor restored cellular survival and migration
67 tutively activated STAT3 restores the mutant c-Kit receptor's transforming ability in 293 cells.
68                                     Although c-Kit receptor signaling promotes angiogenesis in multip
69 ibes the hitherto-unknown role of SWAP-70 in c-kit receptor signaling, a key proliferation and differ
70 n CRTh2(+)ILC2 differentially express CD117 (c-kit receptor), some ILC2 surface phenotypes are unstab
71  addition of the biotinylated ligand for the c-Kit receptor, stem cell factor (SCF), through an avidi
72 a subset of which also coexpressed Thy-1 and c-kit receptors, suggesting that the CD34(+) population
73 rated a functionally and biochemically inert c-Kit receptor that lacked the binding sites for seven e
74  p85(PI3K) is known to bind to the activated c-Kit receptor, the possibility that CRKL interacted wit
75 termolecular tyrosine phosphorylation of the c-kit receptor, thus initiating signal transduction.
76        Stem cell factor (SCF) binding to the c-kit receptor triggers homodimerization and intermolecu
77 oid hematopoietic cells in vitro through the c-kit receptor tyrosine kinase (dominant white spotting,
78  members may negatively modulate function of c-kit receptor tyrosine kinase and thus regulate recepto
79 D63, and CD81 are physically associated with c-kit receptor tyrosine kinase in the human factor-depen
80                                          The c-KIT receptor tyrosine kinase is constitutively activat
81                           Signaling from the c-Kit receptor tyrosine kinase is essential for primordi
82 ent samples, differing classes of activating c-KIT receptor tyrosine kinase mutations have been obser
83 CF) is a growth factor that acts through the c-Kit receptor tyrosine kinase to elicit hematopoietic p
84 n naturally occurring point mutations in the c-kit receptor tyrosine kinase, which suppresses the fun
85 re potent inhibitors of both the Bcr-Abl and c-kit receptor tyrosine kinases and deserve further stud
86 l antibody ACK2, which recognizes the murine c-kit receptor, was used to selectively block the hemato

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。